(Q73166083)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drug (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

I R Judson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P J Beale

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J M Trigo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

W Aherne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Crompton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D Jones

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E Bush

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

B Reigner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

49-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10555122%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006263400888

1 November 2019

exact match

0 references

cites work

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

1 reference

12 December 2020

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts

1 reference

12 December 2020

Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer

1 reference

12 December 2020

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

12 December 2020

Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients

1 reference

12 December 2020

Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile

1 reference

12 December 2020

Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients

1 reference

12 December 2020

Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors

1 reference

12 December 2020

A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors

1 reference

12 December 2020